Department of Clinical Neuroscience, D'Or Institute for Research and Education.
Division of Neurosurgery and.
Neurosurg Focus. 2017 Sep;43(3):E15. doi: 10.3171/2017.6.FOCUS17256.
The neurosurgical endeavor to treat psychiatric patients may have been part of human history since its beginning. The modern era of psychosurgery can be traced to the heroic attempts of Gottlieb Burckhardt and Egas Moniz to alleviate mental symptoms through the ablation of restricted areas of the frontal lobes in patients with disabling psychiatric illnesses. Thanks to the adaptation of the stereotactic frame to human patients, the ablation of large volumes of brain tissue has been practically abandoned in favor of controlled interventions with discrete targets. Consonant with the role of the hypothalamus in the mediation of the most fundamental approach-avoidance behaviors, some hypothalamic nuclei and regions, in particular, have been selected as targets for the treatment of aggressiveness (posterior hypothalamus), pathological obesity (lateral or ventromedial nuclei), sexual deviations (ventromedial nucleus), and drug dependence (ventromedial nucleus). Some recent improvements in outcomes may have been due to the use of stereotactically guided deep brain stimulation and the change of therapeutic focus from categorical diagnoses (such as schizophrenia) to dimensional symptoms (such as aggressiveness), which are nonspecific in terms of formal diagnosis. However, agreement has never been reached on 2 related issues: 1) the choice of target, based on individual diagnoses; and 2) reliable prediction of outcomes related to individual targets. Despite the lingering controversies on such critical aspects, the experience of the past decades should pave the way for advances in the field. The current failure of pharmacological treatments in a considerable proportion of patients with chronic disabling mental disorders is reminiscent of the state of affairs that prevailed in the years before the early psychosurgical attempts. This article reviews the functional organization of the hypothalamus, the effects of ablation and stimulation of discrete hypothalamic regions, and the stereotactic targets that have most often been used in the treatment of psychopathological and behavioral symptoms; finally, the implications of current and past experience are presented from the perspective of how this fund of knowledge may usefully contribute to the future of hypothalamic psychosurgery.
神经外科治疗精神科患者的努力可能自人类历史之初就已存在。现代精神外科学可以追溯到 Gottlieb Burckhardt 和 Egas Moniz 的英勇尝试,他们通过切除额叶限制区域来减轻患有致残性精神疾病患者的精神症状。由于立体定向框架适应了人类患者,因此实际上已经放弃了对大量脑组织的消融,转而采用针对离散靶点的控制性干预。鉴于下丘脑在介导最基本的趋近-回避行为中的作用,一些下丘脑核和区域,特别是后下丘脑、外侧或腹内侧核、腹内侧核、腹内侧核等,已被选为治疗攻击性、病理性肥胖、性偏差和药物依赖的靶点。一些近期的疗效改善可能归因于立体定向引导的深部脑刺激的应用,以及治疗重点从分类诊断(如精神分裂症)转变为维度症状(如攻击性),这些症状在正式诊断方面是非特异性的。然而,人们从未就以下两个相关问题达成一致意见:1)基于个体诊断的目标选择;2)与个体目标相关的结果的可靠预测。尽管在这些关键方面存在争议,但过去几十年的经验应该为该领域的进步铺平道路。目前,相当一部分慢性致残性精神障碍患者的药物治疗失败,这让人想起早期精神外科学尝试之前的情况。本文回顾了下丘脑的功能组织、离散下丘脑区域的消融和刺激的效果,以及最常用于治疗精神病理和行为症状的立体定向靶点;最后,从当前和过去经验的角度提出了这些知识如何有助于下丘脑精神外科学的未来的问题。